CLLS
Price
$2.52
Change
+$0.52 (+26.00%)
Updated
Jul 25 closing price
Capitalization
224.18M
4 days until earnings call
SLN
Price
$6.34
Change
+$0.06 (+0.96%)
Updated
Jul 25 closing price
Capitalization
226.71M
18 days until earnings call
Interact to see
Advertisement

CLLS vs SLN

Header iconCLLS vs SLN Comparison
Open Charts CLLS vs SLNBanner chart's image
Cellectis SA
Price$2.52
Change+$0.52 (+26.00%)
Volume$954.83K
Capitalization224.18M
Silence Therapeutics
Price$6.34
Change+$0.06 (+0.96%)
Volume$35.52K
Capitalization226.71M
CLLS vs SLN Comparison Chart in %
Loading...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLLS vs. SLN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a StrongBuy and SLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CLLS: $2.52 vs. SLN: $6.34)
Brand notoriety: CLLS and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 737% vs. SLN: 35%
Market capitalization -- CLLS: $224.18M vs. SLN: $226.71M
CLLS [@Biotechnology] is valued at $224.18M. SLN’s [@Biotechnology] market capitalization is $226.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • CLLS’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLLS and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 6 TA indicator(s) are bullish while SLN’s TA Score has 2 bullish TA indicator(s).

  • CLLS’s TA Score: 6 bullish, 4 bearish.
  • SLN’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CLLS is a better buy in the short-term than SLN.

Price Growth

CLLS (@Biotechnology) experienced а +38.46% price change this week, while SLN (@Biotechnology) price change was +4.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CLLS is expected to report earnings on Jul 31, 2025.

SLN is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($227M) and CLLS($224M) have the same market capitalization . CLLS YTD gains are higher at: 40.000 vs. SLN (-7.849). CLLS has higher annual earnings (EBITDA): -32.49M vs. SLN (-71.65M). CLLS has more cash in the bank: 242M vs. SLN (137M). SLN has less debt than CLLS: SLN (60K) vs CLLS (91.8M). CLLS has higher revenues than SLN: CLLS (47.6M) vs SLN (27.7M).
CLLSSLNCLLS / SLN
Capitalization224M227M99%
EBITDA-32.49M-71.65M45%
Gain YTD40.000-7.849-510%
P/E RatioN/AN/A-
Revenue47.6M27.7M172%
Total Cash242M137M177%
Total Debt91.8M60K153,000%
FUNDAMENTALS RATINGS
CLLS: Fundamental Ratings
CLLS
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLLSSLN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 5 days ago
77%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 3 days ago
90%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EJTTF6.82N/A
N/A
easyJet Plc
PTABF0.36N/A
N/A
Astra Agro Lestari TBK
CGEMY31.50-0.16
-0.51%
Capgemini SE
BTQQF5.08-0.23
-4.33%
BTQ Technologies Corp.
SNLGF0.15-0.01
-5.58%
SAN LORENZO GOLD CORP

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been loosely correlated with SLN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLLS jumps, then SLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
+26.00%
SLN - CLLS
43%
Loosely correlated
+0.96%
PMVP - CLLS
39%
Loosely correlated
-2.08%
TGTX - CLLS
36%
Loosely correlated
+1.01%
CLGN - CLLS
33%
Poorly correlated
-4.55%
DTIL - CLLS
32%
Poorly correlated
+3.00%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+0.96%
CLLS - SLN
43%
Loosely correlated
+26.00%
NGNE - SLN
35%
Loosely correlated
-0.39%
HLVX - SLN
34%
Loosely correlated
+0.47%
ANNX - SLN
34%
Loosely correlated
-1.57%
IDYA - SLN
33%
Poorly correlated
-1.33%
More